Overview

RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to gather information on the safety and efficacy of risperidone when used in routine clinical practice.
Details
Lead Sponsor:
Janssen Pharmaceutica N.V., Belgium
Treatments:
Risperidone